Major companies like Emerson, Endress+Hauser, Yokogawa, ABB and Krohne owe part of their dominance to strategic patent ...
Only 5% of tax breaks designed to encourage businesses to file more patents are given to SMEs, new findings reveal. Red tape ...
The patent reinforces Rail Vision’s global IP protection strategy, building on previous approvals in regions including the United States, Japan, and India. It further solidifies the company’s position ...
NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026. FORT ...
Large firms take 95% of £2bn in patent tax reliefs, leaving SMEs with just 5%. Discover the implications for small businesses ...
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...
History — and Clarence Thomas — loomed large on Friday as an appellate panel wrestled with the future of the False Claims Act ...
Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.
LogicMark Inc. (NASDAQ: LGMK), the provider of personal emergency response systems, health communication devices and ...
Pharmaceutical Technology on MSN
Biopharma’s 2025 M&A boom: Dealmaking surges as patent pressures intensify
Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results